|
Name |
Accession |
Description |
Interval |
E-value |
| PRK13335 |
PRK13335 |
superantigen-like protein SSL3; Reviewed; |
1-356 |
0e+00 |
|
superantigen-like protein SSL3; Reviewed;
Pssm-ID: 139494 [Multi-domain] Cd Length: 356 Bit Score: 632.93 E-value: 0e+00
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1511612517 1 MKMRTIAKTSLALGLLTTGAITVTTQSVKAEKIQSTKVDKVPTLKAERLAMINITAGANSATTQAANTRQERTPKLEKAP 80
Cdd:PRK13335 1 MKMRTIAKTSLALGLLTTGAITVTTQSVKAEKIQSTKVDKVPTLKAERLAMINITAGANSATTQAANTRQERTPKLEKAP 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1511612517 81 NTNEEKTSASKIEKISQPKQEEQKTLNISATPAPKQEQSQTTTESTTPKTKVTTPPSTNTPQPMQSTKSDTPQSPTIKQA 160
Cdd:PRK13335 81 NTNEEKTSASKIEKISQPKQEEQKSLNISATPAPKQEQSQTTTESTTPKTKVTTPPSTNTPQPMQSTKSDTPQSPTIKQA 160
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1511612517 161 QTDMTPKYEDLRAYYTKPSFEFEKQFGFMLKPWTTVRFMNVIPNRFIYKIALVGKDEKKYKDGPYDNIDVFIVLEDNKYQ 240
Cdd:PRK13335 161 QTDMTPKYEDLRAYYTKPSFEFEKQFGFLLKPWTTVRFMNVIPNRFIYKIALVGKDEKKYKDGPYDNIDVFIVLEDNKYQ 240
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1511612517 241 LKKYSVGGITKTNSKKVNHKVELSITKKDNQGMISRDVSEYMITKEEISLKELDFKLRKQLIEKHNLYGNMGSGTIVIKM 320
Cdd:PRK13335 241 LKKYSVGGITKTNSKKVDHKAELSITKKDNQGMISRDVSEYMITKEEISLKELDFKLRKQLIEKHNLYGNMGSGTIVIKM 320
|
330 340 350
....*....|....*....|....*....|....*.
gi 1511612517 321 KNGGKYTFELHKKLQEHRMADVIDGTNIDNIEVNIK 356
Cdd:PRK13335 321 KNGGKYTFELHKKLQEHRMADVIDGTNIDKIEVNIK 356
|
|
| SSL_OB |
pfam09199 |
Staphylococcal superantigen-like OB-fold domain; This OB-fold domain folds into a ... |
169-253 |
3.08e-34 |
|
Staphylococcal superantigen-like OB-fold domain; This OB-fold domain folds into a five-stranded beta-barrel. Members of this family are found in various staphylococcal toxins described as staphylococcal superantigen-like (SSL) proteins that are related to the staphylococcal enterotoxins (SEs) or superantigens. These SSL proteins of which 11 have so far been characterized have a typical SE tertiary structure consisting of a distinct oligonucleotide/oligosaccharide binding (OB-fold), this domain, linked to a beta-grasp domain, family Stap_Strp_tox_C, pfam02876. SSLs do not bind to T-cell receptors or major histocompatibility complex class II molecules and do not stimulate T cells. SSLs target components of innate immunity, such as complement, Fc receptors, and myeloid cells 2,3,4,5,6,7,8]. SSL protein 7 (SSL7) is the best characterized of the SSLs and binds complement factor C5 and IgA with high affinity and inhibits the end stage of complement activation and IgA binding to FcalphaR.
Pssm-ID: 401224 [Multi-domain] Cd Length: 84 Bit Score: 121.26 E-value: 3.08e-34
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1511612517 169 EDLRAYYTKPSFEFEKQFGFMLKPwTTVRFMNVIPNRFIYKIALVGKDEKKYKDGPYDNIDVFIVLEDNKYQLKKYSVGG 248
Cdd:pfam09199 1 KDLKAYYSKPSFELKNVSGYKEKK-TGKNFLNFTPNNQKYQVALLGKDKEKYKEGEHDNLDVFVVRELEDRNGRKYSVGG 79
|
....*
gi 1511612517 249 ITKTN 253
Cdd:pfam09199 80 VTKKN 84
|
|
|
|
Name |
Accession |
Description |
Interval |
E-value |
| PRK13335 |
PRK13335 |
superantigen-like protein SSL3; Reviewed; |
1-356 |
0e+00 |
|
superantigen-like protein SSL3; Reviewed;
Pssm-ID: 139494 [Multi-domain] Cd Length: 356 Bit Score: 632.93 E-value: 0e+00
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1511612517 1 MKMRTIAKTSLALGLLTTGAITVTTQSVKAEKIQSTKVDKVPTLKAERLAMINITAGANSATTQAANTRQERTPKLEKAP 80
Cdd:PRK13335 1 MKMRTIAKTSLALGLLTTGAITVTTQSVKAEKIQSTKVDKVPTLKAERLAMINITAGANSATTQAANTRQERTPKLEKAP 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1511612517 81 NTNEEKTSASKIEKISQPKQEEQKTLNISATPAPKQEQSQTTTESTTPKTKVTTPPSTNTPQPMQSTKSDTPQSPTIKQA 160
Cdd:PRK13335 81 NTNEEKTSASKIEKISQPKQEEQKSLNISATPAPKQEQSQTTTESTTPKTKVTTPPSTNTPQPMQSTKSDTPQSPTIKQA 160
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1511612517 161 QTDMTPKYEDLRAYYTKPSFEFEKQFGFMLKPWTTVRFMNVIPNRFIYKIALVGKDEKKYKDGPYDNIDVFIVLEDNKYQ 240
Cdd:PRK13335 161 QTDMTPKYEDLRAYYTKPSFEFEKQFGFLLKPWTTVRFMNVIPNRFIYKIALVGKDEKKYKDGPYDNIDVFIVLEDNKYQ 240
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1511612517 241 LKKYSVGGITKTNSKKVNHKVELSITKKDNQGMISRDVSEYMITKEEISLKELDFKLRKQLIEKHNLYGNMGSGTIVIKM 320
Cdd:PRK13335 241 LKKYSVGGITKTNSKKVDHKAELSITKKDNQGMISRDVSEYMITKEEISLKELDFKLRKQLIEKHNLYGNMGSGTIVIKM 320
|
330 340 350
....*....|....*....|....*....|....*.
gi 1511612517 321 KNGGKYTFELHKKLQEHRMADVIDGTNIDNIEVNIK 356
Cdd:PRK13335 321 KNGGKYTFELHKKLQEHRMADVIDGTNIDKIEVNIK 356
|
|
| PRK13042 |
PRK13042 |
superantigen-like protein SSL4; Reviewed; |
1-356 |
2.31e-144 |
|
superantigen-like protein SSL4; Reviewed;
Pssm-ID: 183854 [Multi-domain] Cd Length: 291 Bit Score: 410.18 E-value: 2.31e-144
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1511612517 1 MKMRTIAKTSLALGLLTTGAITVTTQSVKAEKIQSTKVdkvptlkaerlaminitagansattqaantrqertpklekap 80
Cdd:PRK13042 1 MKITTIAKTSLALGLLTTGVITTTTQAANATTPSSTKV------------------------------------------ 38
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1511612517 81 ntnEEKTSASKIEKISQPkqeeQKTLNISATPAPKQEQSQtttesttpktkvttppSTNTPQPMQSTKSDTPQSPTIKQA 160
Cdd:PRK13042 39 ---EAPQSTPPSTKVEAP----QSKPNATTPPSTKVEAPQ----------------QTPNATTPSSTKVETPQSPTTKQV 95
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1511612517 161 QTDMTPKYEDLRAYYTKPSFEFEKQFGFMLKPWTTVRFMNVIPNRFIYKIALVGKDEKKYKDGPYDNIDVFIVLEDNKYQ 240
Cdd:PRK13042 96 PTEINPKFKDLRAYYTKPSLEFKNEIGIILKKWTTIRFMNVVPDYFIYKIALVGKDDKKYGEGVHRNVDVFVVLEENKYN 175
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1511612517 241 LKKYSVGGITKTNSKKVNHKVELSITKKDNQGMISRDVSEYMITKEEISLKELDFKLRKQLIEKHNLYGNMGSGTIVIKM 320
Cdd:PRK13042 176 LEKYSVGGITKSNSKKVDHKAGVRITKEDNKGTISHDVSEFKITKEQISLKELDFKLRKQLIEKHNLYGNVGSGKIVIKM 255
|
330 340 350
....*....|....*....|....*....|....*.
gi 1511612517 321 KNGGKYTFELHKKLQEHRMADVIDGTNIDNIEVNIK 356
Cdd:PRK13042 256 KNGGKYTFELHKKLQENRMADVIDGTNIDNIEVNIK 291
|
|
| PRK13041 |
PRK13041 |
superantigen-like protein SSL2; Reviewed; |
146-356 |
4.10e-55 |
|
superantigen-like protein SSL2; Reviewed;
Pssm-ID: 106078 Cd Length: 231 Bit Score: 180.22 E-value: 4.10e-55
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1511612517 146 STKSDTPQSPTIKQAQTDMTPKyeDLRAYYTKPSFEFEKQFGFMLKPWTTVRFMNVIPNRFIYKIALVGKDEKKYKDGPY 225
Cdd:PRK13041 21 NTTTEKPVHAEKKPIVISENSK--KLKAYYTQPSIEYKNVTGYISFIQPSIKFMNIIDGNSVNNLALIGKDKQHYHTGVH 98
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1511612517 226 DNIDVFIVLEDNKYQLKKYSVGGITKTNSKKVNHKVELSITKKDNQGMISRDVSEYMITKEEISLKELDFKLRKQLIEKH 305
Cdd:PRK13041 99 RNLNIFYVNEDKRFEGAKYSIGGITSANDKAVDLIAEARVIKADHIGEYDYDFFPFKIDKEAMSLKEIDFKLRKYLIDNY 178
|
170 180 190 200 210
....*....|....*....|....*....|....*....|....*....|.
gi 1511612517 306 NLYGNMGSGTIVIKMKNGGKYTFELHKKLQEHRMADVIDGTNIDNIEVNIK 356
Cdd:PRK13041 179 GLYGEMSTGKITVKKKYYGKYTFELDKKLQEDRMSDVINVTDIDRIEIKVR 229
|
|
| PRK13036 |
PRK13036 |
superantigen-like protein SSL11; Reviewed; |
138-355 |
2.51e-46 |
|
superantigen-like protein SSL11; Reviewed;
Pssm-ID: 171852 Cd Length: 227 Bit Score: 157.42 E-value: 2.51e-46
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1511612517 138 TNTPQPMQSTKSDTPQSPTikqaqtdmtpkyEDLRAYYTKPSFEFEKQFGFMLKpwttvRFMNVIPNRFIYKIALVGKDE 217
Cdd:PRK13036 22 TTTAQPVKASTLEVRSQAT------------QDLSEYYKGRGFELTNVSGYKEG-----NKVTFIDNSQLIDVTLTGNEK 84
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1511612517 218 KKYKDG-PYDNIDVFIVLEDNKYQLKKYSVGGITKTNSKKVNHKVE---LSITKKDNQGMISRDVSEYMITKEEISLKEL 293
Cdd:PRK13036 85 LTFKDDeDVSNVDVFVVREGSDKSAITTSIGGITKTNGTQYKDTVQnvnLSISKSTGQHTTSVTSEYYSINKEEISLKEL 164
|
170 180 190 200 210 220
....*....|....*....|....*....|....*....|....*....|....*....|...
gi 1511612517 294 DFKLRKQLIEKHNLYGNM-GSGTIVIKMKNGGKYTFELHKKLQEHRMADVIDGTNIDNIEVNI 355
Cdd:PRK13036 165 DFKLRKHLIDKHDLYKTEpKDSKIRITMKNGGYYTFELNKKLQPHRMGDTIDSRNIEKIEVNL 227
|
|
| PRK13037 |
PRK13037 |
superantigen-like protein SSL1; Reviewed; |
159-356 |
5.26e-43 |
|
superantigen-like protein SSL1; Reviewed;
Pssm-ID: 106074 Cd Length: 226 Bit Score: 148.97 E-value: 5.26e-43
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1511612517 159 QAQTDMTPKYE-DLRAYYTKPSFEFEKQFGFMLKPwTTVRFMNVIPNRFIYKIALVGKDEKKYKDGPYDNIDVFIVLEDN 237
Cdd:PRK13037 29 QAKTEVKQQSEsELKHYYNKPVLERKNVTGYKYTE-KGKDYIDVIVDNQYSQISLVGSDKDKFKDGDNSNIDVFILREGD 107
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1511612517 238 KYQLKKYSVGGITKTNSKKVNHKVELSI--TKKDNQGMISrdvSEYMITKEEISLKELDFKLRKQLIEKHNLYGN-MGSG 314
Cdd:PRK13037 108 SRQATNYSIGGVTKTNSQPYIDYIHTPIleIKKGKEEPQS---SLYQIYKEDISLKELDYRLRERAIKQHGLYSNgLKQG 184
|
170 180 190 200
....*....|....*....|....*....|....*....|..
gi 1511612517 315 TIVIKMKNGGKYTFELHKKLQEHRMADVIDGTNIDNIEVNIK 356
Cdd:PRK13037 185 QITITMKDGKSHTIDLSQKLEKERMGESIDGRQIQKILVEMK 226
|
|
| PRK13040 |
PRK13040 |
superantigen-like protein SSL6; Reviewed; |
151-356 |
1.89e-41 |
|
superantigen-like protein SSL6; Reviewed;
Pssm-ID: 106077 Cd Length: 231 Bit Score: 144.87 E-value: 1.89e-41
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1511612517 151 TPQSPTIKQAQ-TDMTPKYEDLRAYYTKPSFEFEKQFGfMLKPWTTVRFMNVIPNRFIYKIALVGKDEKKYKDGPYDNID 229
Cdd:PRK13040 22 TTESQTVKAAEsTQGQHNYKSLKYYYSKPSIELKNLDG-LYRQKVTDKGVYVWKDRKDYFVGLLGKDIEKYPQGEHDKQD 100
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1511612517 230 VFIVLEDNKYQLKKYSVGGITKTNSKKVNHKVELSITKKDNQGMISRDVSEYMITKEEISLKELDFKLRKQLIEKHNLYG 309
Cdd:PRK13040 101 AFLVIEEETVNGRQYSIGGLSKTNSKEFSKEVDVKVTRKIDESSEKSKDSKFKITKEEISLKELDFKLRKKLMEEEKLYG 180
|
170 180 190 200
....*....|....*....|....*....|....*....|....*....
gi 1511612517 310 --NMGSGTIVIKMKNGGKYTFELHKKLQEHRMADVIDGTNIDNIEVNIK 356
Cdd:PRK13040 181 avNNRKGKIVVKMEDDKFYTFELTKKLQPHRMGDTIDGTKIKEINVELE 229
|
|
| SSL_OB |
pfam09199 |
Staphylococcal superantigen-like OB-fold domain; This OB-fold domain folds into a ... |
169-253 |
3.08e-34 |
|
Staphylococcal superantigen-like OB-fold domain; This OB-fold domain folds into a five-stranded beta-barrel. Members of this family are found in various staphylococcal toxins described as staphylococcal superantigen-like (SSL) proteins that are related to the staphylococcal enterotoxins (SEs) or superantigens. These SSL proteins of which 11 have so far been characterized have a typical SE tertiary structure consisting of a distinct oligonucleotide/oligosaccharide binding (OB-fold), this domain, linked to a beta-grasp domain, family Stap_Strp_tox_C, pfam02876. SSLs do not bind to T-cell receptors or major histocompatibility complex class II molecules and do not stimulate T cells. SSLs target components of innate immunity, such as complement, Fc receptors, and myeloid cells 2,3,4,5,6,7,8]. SSL protein 7 (SSL7) is the best characterized of the SSLs and binds complement factor C5 and IgA with high affinity and inhibits the end stage of complement activation and IgA binding to FcalphaR.
Pssm-ID: 401224 [Multi-domain] Cd Length: 84 Bit Score: 121.26 E-value: 3.08e-34
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1511612517 169 EDLRAYYTKPSFEFEKQFGFMLKPwTTVRFMNVIPNRFIYKIALVGKDEKKYKDGPYDNIDVFIVLEDNKYQLKKYSVGG 248
Cdd:pfam09199 1 KDLKAYYSKPSFELKNVSGYKEKK-TGKNFLNFTPNNQKYQVALLGKDKEKYKEGEHDNLDVFVVRELEDRNGRKYSVGG 79
|
....*
gi 1511612517 249 ITKTN 253
Cdd:pfam09199 80 VTKKN 84
|
|
| PRK13346 |
PRK13346 |
superantigen-like protein SSL7; Reviewed; |
158-356 |
1.85e-30 |
|
superantigen-like protein SSL7; Reviewed;
Pssm-ID: 106304 [Multi-domain] Cd Length: 231 Bit Score: 115.87 E-value: 1.85e-30
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1511612517 158 KQAQTDMTPKYEDLRAYYTKPSFEFEKQFGFM--LKPWTTVRFMNVIPNrfiYKIALVGKDEKKYKDGpYDNIDVFIVLE 235
Cdd:PRK13346 33 KQERVQHLYDIKDLHRYYSSESFEFSNISGKVenYNGSNVVRFNQENQN---HQLFLLGKDKDKYKEG-LEGQNVFVVKE 108
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1511612517 236 DNKYQLKKYSVGGITKTNSKKVNHKVELSItKKDNQGMISRDVSEYMITKEEISLKELDFKLRKQLIEKHNLY-GNMGSG 314
Cdd:PRK13346 109 LIDPNGRLSTVGGVTKKNNKSSETNTHLFV-NKVYGGNLDASIDSFLINKEEVSLKELDFKIRQQLVENYGLYkGTTKYG 187
|
170 180 190 200
....*....|....*....|....*....|....*....|..
gi 1511612517 315 TIVIKMKNGGKYTFELHKKLQEHRMADVIDGTNIDNIEVNIK 356
Cdd:PRK13346 188 KITINLKDEKKEEIDLGDKLQFERMGDVLNSKDIQNIAVTIN 229
|
|
| PRK13035 |
PRK13035 |
superantigen-like protein SSL5; Reviewed; |
170-356 |
8.97e-27 |
|
superantigen-like protein SSL5; Reviewed;
Pssm-ID: 171851 Cd Length: 234 Bit Score: 105.91 E-value: 8.97e-27
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1511612517 170 DLRAYYTKPSFEFEKQFGFMLKPWTTvRFMNVIPNRFIYKIALVGKDEKKYKDGPYDNIDVFIVLEDNKYQLKKYSVGGI 249
Cdd:PRK13035 46 DLRDYYSGASKELKNVTGYRYSKGGK-HYLIFDKNRKFTRVQIFGKDIERFKARKNPGLDIFVVKEAENRNGTVFSYGGV 124
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1511612517 250 TKTNSKKVNHKVELS--ITKKDNQGMISRDVSEYMITKEEISLKELDFKLRKQLIEKHNLYGNMGSGT-IVIKMKNGGKY 326
Cdd:PRK13035 125 TKKNQDAYYDYINAPrfQIKRDEGDGIATYGRVHYIYKEEISLKELDFKLRQYLIQNFDLYKKFPKDSkIKVIMKDGGYY 204
|
170 180 190
....*....|....*....|....*....|
gi 1511612517 327 TFELHKKLQEHRMADVIDGTNIDNIEVNIK 356
Cdd:PRK13035 205 TFELNKKLQTNRMSDVIDGRNIEKIEANIR 234
|
|
| PRK13039 |
PRK13039 |
superantigen-like protein SSL8; Reviewed; |
171-356 |
2.65e-25 |
|
superantigen-like protein SSL8; Reviewed;
Pssm-ID: 171854 Cd Length: 232 Bit Score: 102.08 E-value: 2.65e-25
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1511612517 171 LRAYYTKPSFEFEKQFGFMLKPW-TTVRFMNVIPNRFiyKIALVGKDEKKYKDGPYdNIDVFIVLEDNKYQLKKYSVGGI 249
Cdd:PRK13039 46 LHQYYSGPSYELTNVSGQSQGYYdSNVLLFNQQNQKF--QVFLLGKDENKYKEKTH-GLDVFAVPELVDLDGRIFSVSGV 122
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1511612517 250 TKTNSKKVNHKVE---LSITKKDNQGMISRDvSEYMITKEEISLKELDFKLRKQLIEKHNLY-GNMGSGTIVIKMKNGGK 325
Cdd:PRK13039 123 TKKNVKSIFESLRtpnLLVKKIDDKDGFSID-EFFFIQKEEVSLKELDFKIRKLLIKKYKLYeGSADKGRIVINMKDENK 201
|
170 180 190
....*....|....*....|....*....|.
gi 1511612517 326 YTFELHKKLQEHRMADVIDGTNIDNIEVNIK 356
Cdd:PRK13039 202 YEIDLSDKLDFERMADVINSEQIKNIEVNLK 232
|
|
| PRK13038 |
PRK13038 |
superantigen-like protein SSL10; Reviewed; |
205-356 |
1.13e-23 |
|
superantigen-like protein SSL10; Reviewed;
Pssm-ID: 171853 Cd Length: 227 Bit Score: 97.40 E-value: 1.13e-23
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1511612517 205 RFIYK-----IALVGKDEKKYKDGPYDNIDVFIVLEDNKYQLKKYSVGGITKTN-SKKVNHKVELSITKKDNQGMISRDV 278
Cdd:PRK13038 70 RFKFRgikiqVLLPGNDKSKFQQRSYEGLDVFFVQEKRDKHDIFYTVGGVIQNNkTSGVVSAPILNISKEKGEDAFVKGY 149
|
90 100 110 120 130 140 150
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....
gi 1511612517 279 SeYMITKEEISLKELDFKLRKQLIEKHNLYGNMGS-GTIVIKMKNGGKYTFELHKKLQEHRMADVIDGTNIDNIEVNIK 356
Cdd:PRK13038 150 P-YYIKKEKITLKELDYKLRKHLIEKYGLYKTISKdGRVKISLKDGSFYNLDLRSKLKFKYMGEVIESKQIKDIEVNLK 227
|
|
| PRK13345 |
PRK13345 |
superantigen-like protein SSL9; Reviewed; |
171-355 |
2.88e-22 |
|
superantigen-like protein SSL9; Reviewed;
Pssm-ID: 106303 Cd Length: 232 Bit Score: 93.92 E-value: 2.88e-22
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1511612517 171 LRAYYTKPSFEfEKQFGFMLKPWTTVRFMNVIPNRFIYKIALVGKDEKKYKDGPYdNIDVFIVLEDNKYQLKKYSVGGIT 250
Cdd:PRK13345 46 LHQYYSEESFE-PTNISVKSEDYYGSNVLNFKQRNKAFKVFLLGDDKNKYKEKTH-GLDVFAVPELIDIKGGIYSVGGIT 123
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1511612517 251 KTNSKKVNHKVE---LSITKKDNQGMISRDvSEYMITKEEISLKELDFKLRKQLIEKHNLY-GNMGSGTIVIKMKNGGKY 326
Cdd:PRK13345 124 KKNVRSVFGFVSnpsLQVKKVDAKHGFSIN-ELFFIQKEEVSLKELDFKIRKMLVEKYRLYkGASDKGRIVINMKDEKKY 202
|
170 180
....*....|....*....|....*....
gi 1511612517 327 TFELHKKLQEHRMADVIDGTNIDNIEVNI 355
Cdd:PRK13345 203 VIDLSEKLSFDRMFDVMDSKQIKNIEVNL 231
|
|
| PRK13350 |
PRK13350 |
superantigen-like protein SSL12; Reviewed; |
137-356 |
2.12e-10 |
|
superantigen-like protein SSL12; Reviewed;
Pssm-ID: 171995 [Multi-domain] Cd Length: 238 Bit Score: 60.36 E-value: 2.12e-10
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1511612517 137 STNTPQPMQSTKSDTPQSpTIKQAQTDMtpkyEDLRAYYTKPSFEFEKQFGFM---------LKPWTTVRFMNVIPNRfi 207
Cdd:PRK13350 22 LPQNQKPVFSFYSEAKAY-SIGQDETNI----NELIKYYTQPHFSFSNKWLYQydngniyveLKRYSWSAHISLWGAE-- 94
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1511612517 208 yKIALVGKDEKKYkdgpydnIDVFIVLEDNKYQL----KKYSVGGITKTnSKKVNHKVELSITKKDNQGMISRDVSEYMI 283
Cdd:PRK13350 95 -SWGNINQLKDRY-------VDVFGLKDKDTDQLwwsyRETFTGGVTPA-AKPSDKTYNLFVQYKDKLQTIIGAHKIYQG 165
|
170 180 190 200 210 220 230
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....
gi 1511612517 284 TKEEISLKELDFKLRKQLIEKHNLYG-NMGSGTIVIKMKnGGKYTFELHKKLQEHRMADVIDGTNIDNIEVNIK 356
Cdd:PRK13350 166 NKPVLTLKEIDFRAREALIKNKILYNeNRNKGKLKITGG-GNNYTIDLSKRLHSDLANVYVKNPNKITVDVLFD 238
|
|
| PRK13349 |
PRK13349 |
superantigen-like protein SSL13; Reviewed; |
247-335 |
5.47e-04 |
|
superantigen-like protein SSL13; Reviewed;
Pssm-ID: 106307 Cd Length: 241 Bit Score: 41.20 E-value: 5.47e-04
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1511612517 247 GGITKTNSKKVNHkVELSITKKDNQGMISRDVSEYMITKEEISLKELDFKLRKQLIEKHNLY-GNMGSGTIVIKMKNgGK 325
Cdd:PRK13349 130 GGVTPAATSNDKH-YKLNVTYKDKAETFTGGFPVYEGNKPVLTLKELDFRIRQTLIKSKKLYnNSYNKGQIKITGAD-NN 207
|
90
....*....|
gi 1511612517 326 YTFELHKKLQ 335
Cdd:PRK13349 208 YTIDLSKRLP 217
|
|
| PRK13043 |
PRK13043 |
superantigen-like protein SSL14; Reviewed; |
247-335 |
1.19e-03 |
|
superantigen-like protein SSL14; Reviewed;
Pssm-ID: 171855 Cd Length: 241 Bit Score: 40.08 E-value: 1.19e-03
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1511612517 247 GGITKTNSKKvNHKVELSITKKDNQGMISRDVSEYMITKEEISLKELDFKLRKQLIEKHNLY-GNMGSGTIVIkMKNGGK 325
Cdd:PRK13043 130 GGVTPAATSS-DKPYRLFLKYSDKQQTIIGGHEFYKGNKPVLTLKELDFRIRQTLIKNKKLYnGEFNKGQIKI-TADGNN 207
|
90
....*....|
gi 1511612517 326 YTFELHKKLQ 335
Cdd:PRK13043 208 YTIDLSKKLK 217
|
|
|